O

Ondine Biomedical Inc
LSE:OBI

Watchlist Manager
Ondine Biomedical Inc
LSE:OBI
Watchlist
Price: 10.25 GBX Market Closed
Market Cap: 41.4m GBX
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

OBI latest financial reports are more than 11 years old.

The Relative Value of one OBI stock under the Base Case scenario is 4.84 GBX. Compared to the current market price of 10.25 GBX, Ondine Biomedical Inc is Overvalued by 53%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

OBI Relative Value
Base Case
4.84 GBX
Overvaluation 53%
Relative Value
Price
O
Worst Case
Base Case
Best Case

Valuation Multiples

46.8
P/S
P/S
Price to Sales
46.8
vs History
73
vs Industry
4
Median 3Y
97.3
Median 5Y
97.3
Industry
2.3
Forward
0.3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-4.5
Median 5Y
-4.5
Industry
22.7
Forward
-0
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-6.5
Median 5Y
-6.5
Industry
13.8
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-7.5
Median 5Y
-7.5
Industry
19.6
More Details
4 028.5
P/B
P/B
Price to Book Value
4 028.5
vs History
4
vs Industry
100
Median 3Y
15.9
Median 5Y
14.9
Industry
2.2
More Details
Negative
EV/S
EV/S
Enterprise Value to Sales
N/A
vs History
vs Industry
Median 3Y
-394.5
Median 5Y
-394.5
Industry
2.4
Forward
-0.2
More Details
Negative
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
vs Industry
Median 3Y
-805.1
Median 5Y
-805.1
Industry
5
More Details
3.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
3.2
vs History
90
vs Industry
51
Median 3Y
16.8
Median 5Y
16.8
Industry
12
Forward
0
More Details
3.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
3.1
vs History
90
vs Industry
49
Median 3Y
16.3
Median 5Y
16.3
Industry
16.5
Forward
0
More Details
3.6
EV/OCF
EV/OCF
Enterprise Value to OCF
3.6
vs History
90
vs Industry
51
Median 3Y
19.7
Median 5Y
19.7
Industry
13.5
More Details
3.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
3.6
vs History
90
vs Industry
42
Median 3Y
19.4
Median 5Y
19.4
Industry
17
More Details
Negative
EV/IC
EV/IC
Enterprise Value to IC
N/A
vs History
vs Industry
Median 3Y
-160.2
Median 5Y
-160.2
Industry
1.9
More Details

Multiples Across Competitors

OBI Competitors Multiples
Ondine Biomedical Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Ondine Biomedical Inc
LSE:OBI
41.4m GBP 46.8 -5.4 3.2 3.1
US
Abbott Laboratories
NYSE:ABT
217.5B USD 5.2 16.2 21.8 31.8
US
Intuitive Surgical Inc
NASDAQ:ISRG
185.1B USD 22.2 79.7 61.9 75.1
US
Boston Scientific Corp
NYSE:BSX
151.9B USD 9.1 82 37.4 52.8
US
Stryker Corp
NYSE:SYK
142.2B USD 6.3 47.5 24.6 29.7
IE
Medtronic PLC
NYSE:MDT
113.7B USD 3.4 26.7 14.2 20.1
US
Becton Dickinson and Co
NYSE:BDX
66.1B USD 3.2 37.8 15.8 28.4
DE
Siemens Healthineers AG
XETRA:SHL
58.1B EUR 2.6 29.3 16.7 23.8
US
Edwards Lifesciences Corp
NYSE:EW
41.9B USD 7.7 10 23.6 26
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
290.3B CNY 7.8 23.4 20.5 20.5
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
37.7B USD 1.9 18.9 13.2 16.1

See Also

Summary
OBI intrinsic value, competitors valuation, and company profile.
DCF Valuation
OBI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
OBI stock valuation using valuation multiples.
Wall Street Estimates
OBI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
OBI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 241,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.